Localized Non-Small Cell Lung Cancer (NSCLC) Algorithm Discussion with Dr. Charu Aggarwal
19:14
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
20:14
How to Approach to Ovarian Cancer from Community Oncology Perspective
58:28
UPenn M&T Program Informational Session
26:19
2nd line treatment in advanced HCC and when to switch
55:59
Wharton MBA Industry Spotlight Series: Consulting – Career Management
18:16
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
59:44
Solutions for the Mental Health Care Crisis
22:28